Table 2.
Procedural characteristics.
| Global Cohort | AKI sCyC | No AKI sCyC | p-Value | |
|---|---|---|---|---|
| n = 100 | n = 10 | n = 90 | ||
| Approach | ||||
| Transfemoral—no./total no. (%) | 93 (93%) | 9 (90%) | 84 (93%) | 0.48 |
| Transcarotid—no./total no. (%) | 5 (5%) | 0 | 5 (5.6%) | 0.58 |
| Transaortic—no./total no. (%) | 1 (1%) | 1 (10%) | 0 | 0.1 |
| Valve | ||||
| Sapien—no./total no. (%) | 64 (64%) | 7 (70%) | 57 (63.3%) | 0.48 |
| Corevalve—no./total no. (%) | 34 (34%) | 3 (30%) | 31 (34.4%) | 0.54 |
| Boston Accurate—no./total no. (%) | 2 (2%) | 0 | 2 (2.2%) | 0.81 |
| Sizing—no./total no. (%) | ||||
| 23 mm | 18 (18%) | 2 (20%) | 16 (17.8%) | 0.57 |
| 25 mm | 1 (1%) | 0 | 1 (1.1%) | 0.9 |
| 26 mm | 40 (40%) | 4 (40%) | 36 (40%) | 0.64 |
| 27 mm | 1 (1%) | 0 | 1 (1.1%) | 0.9 |
| 29 mm | 1 (1%) | 0 | 1 (1.1%) | 0.9 |
| 31 mm | 33 (33%) | 4 (40%) | 29 (32.2%) | 0.43 |
| 34 mm | 6 (6%) | 0 | 6 (6.7%) | 0.52 |
| Post Dilatation—no./total no. (%) | 6 (6%) | 0 | 6 (6.7%) | 0.52 |
| Procedure | ||||
| Length of the procedure—min ± DS | 69 ± 21 | 78 ± 30 | 68 ± 20 | 0.16 |
| Contrast media volume—mL ± DS | 140 ± 50 | 138 ± 47 | 141 ± 50 | 0.88 |
| Procedural and Post-procedural Complications | ||||
| Major vascular complications—n (%) | 9 (9%) | 0 | 9 (10%) | 0.37 |
| Minor vascular complications—n (%) | 23 (23%) | 2 (20%) | 21 (23.3%) | 0.58 |
| Red blood cell transfusion—n (%) | 0.5 ± 1 | 1 ± 1.7 | 0.4 ± 0.9 | 0.08 |
| Length of Stay (days) | 8.4 ± 4.6 | 8.4 ± 3.7 | 8.4 ± 4.7 | 0.98 |
Data are presented as mean ± or n (%). AKI = Acute Kidney Injury; BNP = B-type natriuretic peptide; ScyC = serum Cystatin C.